KDM2B and metastatic prostate carcinoma: Since CTCs are the major players in metastasis in the current study, we investigated for the first time the expression of STIM1, ORAI1, and KDM2B simultaneously in Circulating Tumor Cells from the same blood draw of metastatic prostate cancer patients.